Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 1,081-1,092 of 6,115
Drug study icon
CompletedNCT00208156

A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Diego
Why is this study shown?

This study is directly about Depression.

Depression, SchizophreniaDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States
Sponsor
Corcept Therapeutics
Condition
Depression, Schizophrenia
Behavioral study icon
Enrolling By InvitationNCT07052357

Intern Health Study 2025

This summary needs review. Please check the official study record and contact the research team for details.

In Ann Arbor
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
University of Michigan
Condition
Depression
Behavioral study icon
Enrolling By InvitationNCT07685925

Intern Health Study 2026

This summary needs review. Please check the official study record and contact the research team for details.

In Ann Arbor
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
University of Michigan
Condition
Depression
Drug study icon
Enrolling By InvitationNCT05565352

Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)

This summary needs review. Please check the official study record and contact the research team for details.

In Gdansk
Why is this study shown?

This study is directly about Depression.

Depression, PTSD, ...DrugFrom 18 Years to 90 Years
Countries
Poland
Sponsor
Medical University of Gdansk
Condition
Depression, PTSD, ...
Behavioral study icon
Enrolling By InvitationNCT06880796

Mindfulness-Based Therapy for Serious Mental Illness

This summary needs review. Please check the official study record and contact the research team for details.

In Providence
Why is this study shown?

This study is directly about Depression.

Depression, Schizophrenia, ...BehavioralOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Depression, Schizophrenia, ...
Behavioral study icon
RecruitingISRCTN90050599

Testing online, self-help single session interventions for UK young people with low mood: the Unlock Wellbeing study

This study is looking at whether psychoeducation can help people with Elevated depressive symptoms or Mental and Behavioural Disorders. Participants take part in psychoeducation and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 13 Years to 18 Years
Countries
United Kingdom
Sponsor
University of Bath
Condition
Depression
Drug study icon
CompletedEUCTR 2020-001348-25

A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Czechia, Denmark, Germany, ...
Sponsor
COMPASS Pathways, Ltd
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2018-003252-20

A 52-Week Open-Label Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom, Finland, Poland, ...
Sponsor
ACADIA Pharmaceuticals Inc
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2015-003957-16

A randomised controlled trial of oral S-ketamine as add-on medication for patients with treatment-resistant major depressive disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Netherlands
Sponsor
University Medical Centre Groningen
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.